Please provide your email address to receive an email when new articles are posted on . Men, along with clinicians with more than 4 years’ experience, were more likely than women and less experienced ...
The potential of biologic agents to influence malignant processes has revolutionized cancer therapy. The biologic therapy causes modulation of immune responses ...
Biologic response modifiers presently approved in the USA for use in various rheumatic inflammatory diseases include three TNF inhibitors (etanercept, infliximab and adalimumab), a B-cell-directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results